Dong-Yeon Kim / Ph.D.
· Position : Assistant professor, Department of Nuclear Medicine, Chonnam National University Medical School & Hwasun Hospital
· Interesting field : Development of Radiopharmaceuticals, Molecular Imaging, Radioisotope Labeling
Tel+82-61-379-7268/ 2872
E-mailblueburr@gmail.com
Education
- 2012 - 2017: Postdoctoral fellow, Department of Nuclear Medicine, Chonnam National University Hwasun Hospital
- 2007 - 2012: Researcher, Department of Nuclear Medicine, Chonnam National University Hwasun Hospital
- 2008 - 2012: Ph.D., Dongguk University-seoul, Department of chemistry
- 2006 - 2008: M.S., Dongguk University-seoul, Department of chemistry
- 1999 - 2006: B.S., Dongguk University-seoul, Department of chemistry
- 2007 - 2012: Researcher, Department of Nuclear Medicine, Chonnam National University Hwasun Hospital
- 2008 - 2012: Ph.D., Dongguk University-seoul, Department of chemistry
- 2006 - 2008: M.S., Dongguk University-seoul, Department of chemistry
- 1999 - 2006: B.S., Dongguk University-seoul, Department of chemistry
Experience
- 2017 - Present: Researcher (Grade 4), Department of Nuclear Medicine, Chonnam National University Hwasun Hospital
- 2013 - 2017: Researcher (Grade 5), Department of Nuclear Medicine, Chonnam National University Hwasun Hospital
- 2009 - 2013: Researcher (Grade 6), Department of Nuclear Medicine, Chonnam National University Hwasun Hospital
- 2007 - 2009: Researcher, Department of Nuclear Medicine, Chonnam National University Hwasun Hospital
- 2013 - 2017: Researcher (Grade 5), Department of Nuclear Medicine, Chonnam National University Hwasun Hospital
- 2009 - 2013: Researcher (Grade 6), Department of Nuclear Medicine, Chonnam National University Hwasun Hospital
- 2007 - 2009: Researcher, Department of Nuclear Medicine, Chonnam National University Hwasun Hospital
Honors and Award
- Alavi-Mandell Award, Society of Nuclear Medicine and Molecular Imaging (2016)
- Young Investigator Award, The China, Japan, Korea Conference on Nuclear Medicine and The Korea Society of Nuclear Medicine (2013)
- Asian Young Investigator Award, The Japanese Society of Nuclear Medicine (2013)
- Travel Scholarship, The World Molecular Imaging Congress (2012)
- Cardiovascular Council Basic Science Young Investigator Award Second Place, The Society of Nuclear Medicine (2011)
- Young Investigator Award Travel Grant, The Society of Nuclear Medicine (2011)
- Young Investigator’s Award, Korean Society of Molecular Imaging (2010)
- Travel Scholarship, The World Molecular Imaging Congress (2010)
- Young Investigator Award, The China, Japan, Korea Conference on Nuclear Medicine and The Korea Society of Nuclear Medicine (2013)
- Asian Young Investigator Award, The Japanese Society of Nuclear Medicine (2013)
- Travel Scholarship, The World Molecular Imaging Congress (2012)
- Cardiovascular Council Basic Science Young Investigator Award Second Place, The Society of Nuclear Medicine (2011)
- Young Investigator Award Travel Grant, The Society of Nuclear Medicine (2011)
- Young Investigator’s Award, Korean Society of Molecular Imaging (2010)
- Travel Scholarship, The World Molecular Imaging Congress (2010)
Academic Activity
- 2017- Present: Member of a radiopharmaceutical committee, Korean Society of Nuclear Medicine
- 2014 - Present: Editorial board, Korean Society of Nuclear Medicine
- 2013 - Present: Full member, Korean Society of Nuclear Medicine
- 2011 - Present: Full member, Society of Nuclear Medicine and Molecular Imaging
- 2010 - Present: Full member, World Molecular Imaging Congress
- 2010 - Present: Full member, The Korean Society of Molecular Imaging
- 2014 - Present: Editorial board, Korean Society of Nuclear Medicine
- 2013 - Present: Full member, Korean Society of Nuclear Medicine
- 2011 - Present: Full member, Society of Nuclear Medicine and Molecular Imaging
- 2010 - Present: Full member, World Molecular Imaging Congress
- 2010 - Present: Full member, The Korean Society of Molecular Imaging
Publications
-64Cu-Labeled Repebody Molecules for Imaging of Epidermal Growth Factor Receptor Expressing Tumors. J Nucl Med. 2017. Article in Press (2016 IF: 6.646, Corresponding Author)
- Small bowel metastasis from hepatocellular carcinoma detected by F-18 FDG PET/CT but not by C-11 acetate PET/CT. Clinical Nuclear Medicine. 2017 Article in Press (2016 IF: 4.563, Co-author)
- Potential visualization of sorafenib-induced acidosis using 11-C-acetate positron emission tomographycComputed Tomography in Patients with Hepatocellular Carcinoma. Clinical Nuclear Medicine. 2017 Article in Press (2016 IF: 4.563, Co-author)
- Engineering of monobody conjugates for human EphA2-specific optical imaging. PLoS ONE. 2017 12(7): e0180786 (2016 IF: 2.806, Co-author)
- Optimization of diagnostic performance for differentiation of recurrence from radiation necrosis in patients with metastatic brain tumors using tumor volume-corrected -11C-methionine uptake. EJNMMI Research. 2017; 7: 45 (2016 IF: 2.033, Co-author)
- A high-affinity repebody for molecular imaging of EGFR-expressing malignant tumors. Theranostics. 2017; 7: 2620-2633 (2016 IF: 8.712, First author)
- Comparative evaluation of the algorithms for parametric mapping of the novel myocardial PET imaging agent 18F-FPTP. Ann Nucl Med. 2017; 31: 469-479 (2016 IF: 1.396, Co-author)
- Comparison of reconstruction methods in a small animal cardiac PET study using a 18F-labeled myocardial agent, [18 F]FPTP. Iranian Journal of Radiology. 2017; 14(1)e26806 (2016 IF: 0.554, Corresponding Author)
- Prognostic value of post-treatment metabolic tumor volume from 11 C-methionine PET/CT in recurrent malignant glioma. Neurosurg Rev. 2017; 40: 223-229 (2016 IF: 2.060, Co-author)
- RGD Peptide Cell-Surface Display Enhances the Targeting and Therapeutic Efficacy of Attenuated Salmonella-mediated Cancer Therapy. Theranostics. 2016; 6; 1672-1682 (2016 IF: 8.712, Co-author)
- Radiolabeled Phosphonium Salts as Mitochondrial Voltage Sensors for Positron Emission Tomography Myocardial Imaging Agents. Nucl Med Mol Imaging. 2016; 50; 185-195 (Corresponding Author)
- Comparison of 18 F-labeled fluoroalkylphosphonium cations with 13 N-NH3 for PET myocardial perfusion imaging. J Nucl Med. 2015; 56; 1581-1586 (2016 IF: 6.646, First author)
- Isolation and characterization of a monobody with a fibronectin domain III scaffold that specifically binds EphA2. PLoS ONE. 2015 10(7): e0132976 (2016 IF: 2.806, Co-author)
- Radiosynthesis and evaluation of 18 F-labeled aliphatic phosphonium cations as a myocardial imaging agent for positron emission tomography. Nuclear Medicine Communications. 2015; 36; 747-754 (2016 IF: 1.472, First author)
- Synthesis and evaluation of 18 F-labeled fluoroalkyl triphenylphosphonium salts as mitochondrial voltage sensors in PET myocardial imaging. Methods in Molecular Biology. 2015; 1265; 59-72, (First author)
- Synthesis and evaluation of 18 F-labeled pyrido[3,2-b]pyrazine derivative as a potential imaging agent for non-small-cell lung cancer. Bulletin of the Korean Chemical Society. 2015 ; 36 ;1778-1783 (2016 IF: 0.602, Co-author)
- In-house development of an optimized synthetic module for routine [11 C]acetate production. Nuclear Medicine Communications. 2015; 36; 102–106 (2016 IF: 1.472, Corresponding Author)
- Comparison of the cardiac microPET images obtained using [18 F]FPTP and [13N]NH3 in rat myocardial infarction. ACS Med. Chem. Lett. 2014; 5; 1124-1128 (2016 IF: 3.746, First author)
- Development of the [11C] Acetate Synthesis Module. Journal of the Korean Physical Society. 2013; 63(7); 1390-1394 (2016 IF: 0.467, Co-author)
- Evaluation of a mitochondrial voltage sensor, (18F-fluoropentyl)triphenylphosphonium cation, in a rat myocardial infarction model. J. Nucl. Med. 2012; 53:1779-1785 (2016 IF: 6.646, First author)
- Synthesis of [18F]-labeled (2-(2-fluoroethoxy)ethyl)tris(4-methoxyphenyl)phosphonium cation as a potential agent for positron emission tomography myocardial imaging. Nuclear Medicine and Biology. 2012; 39; 1093–1098 (2016 IF: 2.426, First author)
- Synthesis of [18F]-labeled (6-fluorohexyl)triphenylphosphonium cation as a potential agent for myocardial imaging using positron emission tomography. Bioconjugate Chem. 2012; 23; 431-437. (2016 IF: 4.818, First author)
- Synthesis of [18F]-labeled (2-(2-fluoroethoxy)ethyl)triphenylphosphonium cation as a potential agent for myocardial imaging using positron emission tomography. Bioorg. Med. Chem. Lett. 2012; 22; 319–322. (2016 IF: 2.454, First author)
- Synthesis and characterization of a 68Ga-labeled N-(2-diethylaminoethyl)benzamide derivative as potential PET Probe for malignant melanoma. Bioorg. Med. Chem. 2012; 20; 4915–4920. (2016 IF: 2.930, Co-author)
- Synthesis and evaluation of a novel 68Ga-labeled DOTA-benzamide derivative for malignant melanoma imaging. Bioorg. Med. Chem. Lett. 2012; 22; 5288–5292 (2016 IF: 2.454, Co-author)
- Small bowel metastasis from hepatocellular carcinoma detected by F-18 FDG PET/CT but not by C-11 acetate PET/CT. Clinical Nuclear Medicine. 2017 Article in Press (2016 IF: 4.563, Co-author)
- Potential visualization of sorafenib-induced acidosis using 11-C-acetate positron emission tomographycComputed Tomography in Patients with Hepatocellular Carcinoma. Clinical Nuclear Medicine. 2017 Article in Press (2016 IF: 4.563, Co-author)
- Engineering of monobody conjugates for human EphA2-specific optical imaging. PLoS ONE. 2017 12(7): e0180786 (2016 IF: 2.806, Co-author)
- Optimization of diagnostic performance for differentiation of recurrence from radiation necrosis in patients with metastatic brain tumors using tumor volume-corrected -11C-methionine uptake. EJNMMI Research. 2017; 7: 45 (2016 IF: 2.033, Co-author)
- A high-affinity repebody for molecular imaging of EGFR-expressing malignant tumors. Theranostics. 2017; 7: 2620-2633 (2016 IF: 8.712, First author)
- Comparative evaluation of the algorithms for parametric mapping of the novel myocardial PET imaging agent 18F-FPTP. Ann Nucl Med. 2017; 31: 469-479 (2016 IF: 1.396, Co-author)
- Comparison of reconstruction methods in a small animal cardiac PET study using a 18F-labeled myocardial agent, [18 F]FPTP. Iranian Journal of Radiology. 2017; 14(1)e26806 (2016 IF: 0.554, Corresponding Author)
- Prognostic value of post-treatment metabolic tumor volume from 11 C-methionine PET/CT in recurrent malignant glioma. Neurosurg Rev. 2017; 40: 223-229 (2016 IF: 2.060, Co-author)
- RGD Peptide Cell-Surface Display Enhances the Targeting and Therapeutic Efficacy of Attenuated Salmonella-mediated Cancer Therapy. Theranostics. 2016; 6; 1672-1682 (2016 IF: 8.712, Co-author)
- Radiolabeled Phosphonium Salts as Mitochondrial Voltage Sensors for Positron Emission Tomography Myocardial Imaging Agents. Nucl Med Mol Imaging. 2016; 50; 185-195 (Corresponding Author)
- Comparison of 18 F-labeled fluoroalkylphosphonium cations with 13 N-NH3 for PET myocardial perfusion imaging. J Nucl Med. 2015; 56; 1581-1586 (2016 IF: 6.646, First author)
- Isolation and characterization of a monobody with a fibronectin domain III scaffold that specifically binds EphA2. PLoS ONE. 2015 10(7): e0132976 (2016 IF: 2.806, Co-author)
- Radiosynthesis and evaluation of 18 F-labeled aliphatic phosphonium cations as a myocardial imaging agent for positron emission tomography. Nuclear Medicine Communications. 2015; 36; 747-754 (2016 IF: 1.472, First author)
- Synthesis and evaluation of 18 F-labeled fluoroalkyl triphenylphosphonium salts as mitochondrial voltage sensors in PET myocardial imaging. Methods in Molecular Biology. 2015; 1265; 59-72, (First author)
- Synthesis and evaluation of 18 F-labeled pyrido[3,2-b]pyrazine derivative as a potential imaging agent for non-small-cell lung cancer. Bulletin of the Korean Chemical Society. 2015 ; 36 ;1778-1783 (2016 IF: 0.602, Co-author)
- In-house development of an optimized synthetic module for routine [11 C]acetate production. Nuclear Medicine Communications. 2015; 36; 102–106 (2016 IF: 1.472, Corresponding Author)
- Comparison of the cardiac microPET images obtained using [18 F]FPTP and [13N]NH3 in rat myocardial infarction. ACS Med. Chem. Lett. 2014; 5; 1124-1128 (2016 IF: 3.746, First author)
- Development of the [11C] Acetate Synthesis Module. Journal of the Korean Physical Society. 2013; 63(7); 1390-1394 (2016 IF: 0.467, Co-author)
- Evaluation of a mitochondrial voltage sensor, (18F-fluoropentyl)triphenylphosphonium cation, in a rat myocardial infarction model. J. Nucl. Med. 2012; 53:1779-1785 (2016 IF: 6.646, First author)
- Synthesis of [18F]-labeled (2-(2-fluoroethoxy)ethyl)tris(4-methoxyphenyl)phosphonium cation as a potential agent for positron emission tomography myocardial imaging. Nuclear Medicine and Biology. 2012; 39; 1093–1098 (2016 IF: 2.426, First author)
- Synthesis of [18F]-labeled (6-fluorohexyl)triphenylphosphonium cation as a potential agent for myocardial imaging using positron emission tomography. Bioconjugate Chem. 2012; 23; 431-437. (2016 IF: 4.818, First author)
- Synthesis of [18F]-labeled (2-(2-fluoroethoxy)ethyl)triphenylphosphonium cation as a potential agent for myocardial imaging using positron emission tomography. Bioorg. Med. Chem. Lett. 2012; 22; 319–322. (2016 IF: 2.454, First author)
- Synthesis and characterization of a 68Ga-labeled N-(2-diethylaminoethyl)benzamide derivative as potential PET Probe for malignant melanoma. Bioorg. Med. Chem. 2012; 20; 4915–4920. (2016 IF: 2.930, Co-author)
- Synthesis and evaluation of a novel 68Ga-labeled DOTA-benzamide derivative for malignant melanoma imaging. Bioorg. Med. Chem. Lett. 2012; 22; 5288–5292 (2016 IF: 2.454, Co-author)